Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
14-36
Author(s):
Peter J. Oates
Is C-Peptide Replacement the Missing Link for Successful Treatment of Neurological Complications in Type 1 Diabetes?
Journal:
Current Drug Targets
Volume:
9
Page:
37-46
Author(s):
Anders A.F. Sima and Hideki Kamiya
Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
Journal:
Current Drug Targets
Volume:
9
Page:
60-67
Author(s):
Norman E. Cameron and Mary A. Cotter
Cyclooxygenase-2 Pathway as a Potential Therapeutic Target in Diabetic Peripheral Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
68-76
Author(s):
Rodica Pop-Busui, Aaron P. Kellogg and Hsinlin Thomas Cheng
The Potential Role of Angiotensin Converting Enzyme and Vasopeptidase Inhibitors in the Treatment of Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
77-84
Author(s):
Mark A. Yorek
The Antioxidant Response as a Drug Target in Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
94-100
Author(s):
Andrea M. Vincent, James L. Edwards, Mahdieh Sadidi and Eva L. Feldman
Advanced Glycation and ROS: A Link between Diabetes and Heart Failure
Journal:
Current Vascular Pharmacology
Volume:
6
Page:
44-51
Author(s):
Armando Rojas, Enrique Mercadal, Hector Figueroa and Miguel A. Morales
Endothelial Dysfunction, Impaired Endogenous Platelet Inhibition and Platelet Activation in Diabetes and Atherosclerosis
Journal:
Current Vascular Pharmacology
Volume:
6
Page:
52-60
Author(s):
Andreas Schafer and Johann Bauersachs
Pharmacologic Intervention in Axonal Excitability: In Vivo Assessment of Nodal Persistent Sodium Currents in Human Neuropathies
Journal:
Current Molecular Pharmacology
Volume:
1
Page:
61-67
Author(s):
Satoshi Kuwabara and Sonoko Misawa
A New Light Device for Wound Healing
Journal:
Recent Patents on Biomedical Engineering (Discontinued)
Volume:
1
Page:
13-17
Author(s):
Rachel Lubart, Zvi Landau, Anat Lipovsky and Yeshayahu Nitzan